The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $9,651.50 to provide RABAVERT rabies vaccine with diluents. This award is part of Amerisourcebergen's broader contract vehicle with DLA, an indefinite delivery contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, to deliver a wide range of pharmaceutical products and medical supplies to DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of RABAVERT rabies vaccine with diluents. The contract, valued at $2,095.80, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of March 14, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $1,198.20 Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA). The contract is to provide RABAVERT rabies vaccine with diluents. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a wide range of pharmaceutical products and...
This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The firm fixed-price delivery order, valued at $12,017.42, has an ultimate completion date of June 27, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,944.63, is a Firm Fixed Price Delivery Order for RABAVERT RABIES VACC W-DILUENTS. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of RABAVERT rabies vaccines with diluents, with a total ceiling value of $9,651.50. The contract has an ultimate completion date of June 21, 2024 and was awarded on June 20, 2024. It is a Delivery Order contract with a Firm Fixed Price pricing type, issued by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense. Amerisourcebergen holds a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) is for the delivery of RABAVERT rabies vaccine vials with diluents. The contract has a ceiling value of $1,930.30 and an ultimate completion date of April 17, 2024. This is a Firm Fixed Price delivery order contract with no set-aside designation. Amerisourcebergen is a major pharmaceutical distribution company that holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $9,651.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract provides for the delivery of RABAVERT RABIES VACC W-DILUENTS, with a completion date of June 14, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The company...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,497.82 to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, for the supply of RABAVERT rabies vaccine with diluents. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp by DLA, which serves as the primary contract vehicle for the company to deliver pharmaceutical...
This federal contract award, valued at $4,524.52, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the supply of RABAVERT Rabies Vaccine with diluents. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA to provide a comprehensive range of pharmaceutical products and...